|
Mr. Ed Mathers was named executive vice president, corporate development and venture, in August 2006. In this role, he is responsible for the company’s licensing and business development activities and is a key leader of the company's MedImmune Ventures, Inc. team evaluating investment opportunities. He joined MedImmune as vice president, corporate development, in 2002 and was promoted to senior vice president, corporate development, in February 2005. Prior to joining MedImmune, Mr. Mathers was vice president of marketing and corporate licensing and acquisitions at Inhale Therapeutic Systems. Previously, he enjoyed a successful 15-year career at Glaxo Wellcome, Inc. (GlaxoSmithKline), holding a number of increasingly responsible positions in sales and marketing. Mr. Mathers started his career at Ortho Pharmaceuticals Corporation (a division of Johnson & Johnson) as a researcher. He holds a bachelor’s degree in chemistry from North Carolina State University.
| 